von Willebrand Factor, antagonists & inhibitors
- Name
- von Willebrand Factor, antagonists & inhibitors
- Accession Number
- DBCAT001759
- Description
Not Available
- Drugs
Drug Drug Description Caplacizumab A von Willebrand factor (vWF)-directed antibody fragment used to treat acquired thrombotic thrombocytopenic purpura (aTTP). Von Willebrand factor human A blood clotting factor used to manage bleeding episodes in von Willebrand disease and hemophilia A. - Drugs & Drug Targets